🔧 PART 19: EU Joint Scientific Consultation (JSC) – Are you ready for the next request window?

Series: monthly news from the EU HTA workshop

 

🔍 Deciding when to request a JSC is becoming a critical strategic step in EU market access under the Joint Clinical Assessment (JCA) framework.

 

📋 Our decision checklist supports teams to rapidly assess:

✔️ Eligibility and optimal timing
✔️ Key triggers (e.g., comparator uncertainty, endpoint strategy, RWE/ITC use)
✔️ Situations where a JSC adds limited value
✔️ Readiness for submission in the next request window

 

➡️ In summary: If your pivotal design is still adaptable and major evidence uncertainties remain, a JSC can de-risk your EU evidence strategy early.

 

📌 We have developed a structured checklist that guides you through this decision and supports you for a successful JSC application. You are welcome to contact us!

 

We are providing you with insights from our current work on EU HTA.